Since the description of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) and their roles in tumor immune evasion3,4, understanding the interaction between immune cells and cancer cells has become increasingly important as a starting point for the development of new immunotherapies5–7. This evidence concerns the gene PDCD1 and neoplasm.